These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12089677)

  • 21. Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.
    Miguel DC; Yokoyama-Yasunaka JK; Andreoli WK; Mortara RA; Uliana SR
    J Antimicrob Chemother; 2007 Sep; 60(3):526-34. PubMed ID: 17584801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis.
    Schmidt-Ott R; Klenner T; Overath P; Aebischer T
    Trans R Soc Trop Med Hyg; 1999; 93(1):85-90. PubMed ID: 10492799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current treatment for cutaneous leishmaniasis: a review.
    Palumbo E
    Am J Ther; 2009; 16(2):178-82. PubMed ID: 19300044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs.
    Garnier T; Mäntylä A; Järvinen T; Lawrence J; Brown M; Croft S
    J Antimicrob Chemother; 2007 Oct; 60(4):802-10. PubMed ID: 17715126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical treatment with nanoliposomal Amphotericin B reduces early lesion growth but fails to induce cure in an experimental model of cutaneous leishmaniasis caused by Leishmania mexicana.
    Varikuti S; Oghumu S; Saljoughian N; Pioso MS; Sedmak BE; Khamesipour A; Satoskar AR
    Acta Trop; 2017 Sep; 173():102-108. PubMed ID: 28602835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The leishmanicidal effect of (3S)-16,17-didehydrofalcarinol, an oxylipin isolated from Tridax procumbens, is independent of NO production.
    Martín-Quintal Z; del Rosario García-Miss M; Mut-Martín M; Matus-Moo A; Torres-Tapia LW; Peraza-Sánchez SR
    Phytother Res; 2010 Jul; 24(7):1004-8. PubMed ID: 19953523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran.
    Alborzi A; Pouladfar GR; Fakhar M; Motazedian MH; Hatam GR; Kadivar MR
    Am J Trop Med Hyg; 2008 Sep; 79(3):435-7. PubMed ID: 18784238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo antileishmanial activity of 2-amino-4,6-dimethylpyridine derivatives against Leishmania mexicana.
    Abdala H; Alvarez N; Delmas F; Di Giorgio C; Robert JM; Le Baut G; Le Pape P
    Parasite; 2002 Dec; 9(4):367-70. PubMed ID: 12514953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hexadecyl-phosphorylcholine ointment for treatment of cutaneous leishmaniasis: an animal trial.
    Iqbal J; Bukhari I; Jamshid M; Bashir S; Masoom Yasinzai M; Anwar M
    East Mediterr Health J; 2006 Sep; 12(5):685-9. PubMed ID: 17333810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool.
    Reimão JQ; Trinconi CT; Yokoyama-Yasunaka JK; Miguel DC; Kalil SP; Uliana SR
    J Microbiol Methods; 2013 May; 93(2):95-101. PubMed ID: 23466934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined interleukin-12 and topical chemotherapy for established Leishmaniasis drastically reduces tissue parasitism and relapses in susceptible mice.
    Fernandes AP; Carvalho FA; Tavares CA; Santiago HC; Castro GA; Tafuri WL; Ferreira LA; Gazzinelli RT
    J Infect Dis; 2001 Jun; 183(11):1646-52. PubMed ID: 11343214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicological analysis and effectiveness of oral Kalanchoe pinnata on a human case of cutaneous leishmaniasis.
    Torres-Santos EC; Da Silva SA; Costa SS; Santos AP; Almeida AP; Rossi-Bergmann B
    Phytother Res; 2003 Aug; 17(7):801-3. PubMed ID: 12916081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is leishmaniasis ever cured?
    de Rossell RA; de Duran RJ; Rossell O; Rodríguez AM
    Trans R Soc Trop Med Hyg; 1992; 86(3):251-3. PubMed ID: 1412645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug discovery and development of vaccination strategies for the treatment and prevention of cutaneous leishmaniasis].
    Schurigt U; Moll H
    Pharm Unserer Zeit; 2009; 38(6):532-7. PubMed ID: 19862713
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.
    Arevalo J; Ramirez L; Adaui V; Zimic M; Tulliano G; Miranda-Verástegui C; Lazo M; Loayza-Muro R; De Doncker S; Maurer A; Chappuis F; Dujardin JC; Llanos-Cuentas A
    J Infect Dis; 2007 Jun; 195(12):1846-51. PubMed ID: 17492601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Apigenin and Miltefosine Combination Therapy against Experimental Cutaneous Leishmaniasis.
    Emiliano YSS; Almeida-Amaral EE
    J Nat Prod; 2018 Aug; 81(8):1910-1913. PubMed ID: 30095915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral metabolism and efficacy of Kalanchoe pinnata flavonoids in a murine model of cutaneous leishmaniasis.
    Muzitano MF; Falcão CA; Cruz EA; Bergonzi MC; Bilia AR; Vincieri FF; Rossi-Bergmann B; Costa SS
    Planta Med; 2009 Mar; 75(4):307-11. PubMed ID: 19085683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana.
    Al-Mohammed HI; Chance ML; Bates PA
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3274-80. PubMed ID: 16048936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro maintenance of Leishmania amastigotes directly from lesions: advantages and limitations.
    Hodgkinson VH; Soong L
    J Parasitol; 1997 Oct; 83(5):953-6. PubMed ID: 9379307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
    Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
    Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.